Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
21.27
-0.29 (-1.35%)
Nov 20, 2024, 4:00 PM EST - Market closed
GRDN Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for GRDN stock have an average target of 22.5, with a low estimate of 21 and a high estimate of 24. The average target predicts an increase of 5.78% from the current stock price of 21.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for GRDN stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 |
---|---|
Strong Buy | 1 |
Buy | 1 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +12.83% | Nov 15, 2024 |
Stephens & Co. | Stephens & Co. | Buy Initiates $21 | Buy | Initiates | $21 | -1.27% | Oct 22, 2024 |
Truist Securities | Truist Securities | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +3.43% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
1.22B
from 1.05B
Increased by 16.14%
Revenue Next Year
1.34B
from 1.22B
Increased by 10.62%
EPS This Year
0.79
EPS Next Year
0.88
from 0.79
Increased by 11.59%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 1.3B | 1.4B | 1.4B |
Avg | 1.2B | 1.3B | 1.4B |
Low | 1.2B | 1.3B | 1.3B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 19.6% | 14.1% | 6.3% |
Avg | 16.1% | 10.6% | 2.5% |
Low | 11.5% | 6.1% | -2.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 0.85 | 0.91 | 1.05 |
Avg | 0.79 | 0.88 | 0.99 |
Low | 0.74 | 0.84 | 0.91 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | 15.3% | 18.8% |
Avg | - | 11.6% | 12.3% |
Low | - | 6.4% | 3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.